58 related articles for article (PubMed ID: 35681729)
1. Penfluridol as a Candidate of Drug Repurposing for Anticancer Agent.
Tuan NM; Lee CH
Molecules; 2019 Oct; 24(20):. PubMed ID: 31614431
[TBL] [Abstract][Full Text] [Related]
2. Synergistic Tumor Inhibition via Energy Elimination by Repurposing Penfluridol and 2-Deoxy-D-Glucose in Lung Cancer.
Lai TC; Lee YL; Lee WJ; Hung WY; Cheng GZ; Chen JQ; Hsiao M; Chien MH; Chang JH
Cancers (Basel); 2022 Jun; 14(11):. PubMed ID: 35681729
[TBL] [Abstract][Full Text] [Related]
3. Autophagosome accumulation-mediated ATP energy deprivation induced by penfluridol triggers nonapoptotic cell death of lung cancer via activating unfolded protein response.
Hung WY; Chang JH; Cheng Y; Cheng GZ; Huang HC; Hsiao M; Chung CL; Lee WJ; Chien MH
Cell Death Dis; 2019 Jul; 10(8):538. PubMed ID: 31308361
[TBL] [Abstract][Full Text] [Related]
4. Penfluridol triggers mitochondrial-mediated apoptosis and suppresses glycolysis in colorectal cancer cells through down-regulating hexokinase-2.
Wang NN; Zhang PZ; Zhang J; Wang HN; Li L; Ren F; Dai PF; Li H; Lv XF
Anat Rec (Hoboken); 2021 Mar; 304(3):520-530. PubMed ID: 32470200
[TBL] [Abstract][Full Text] [Related]
5. The diabetes medication canagliflozin promotes mitochondrial remodelling of adipocyte via the AMPK-Sirt1-Pgc-1α signalling pathway.
Yang X; Liu Q; Li Y; Tang Q; Wu T; Chen L; Pu S; Zhao Y; Zhang G; Huang C; Zhang J; Zhang Z; Huang Y; Zou M; Shi X; Jiang W; Wang R; He J
Adipocyte; 2020 Dec; 9(1):484-494. PubMed ID: 32835596
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial biogenesis: pharmacological approaches.
Valero T
Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of AMPK/PFKFB3 mediated glycolysis synergizes with penfluridol to suppress gallbladder cancer growth.
Hu J; Cao J; Jin R; Zhang B; Topatana W; Juengpanich S; Li S; Chen T; Lu Z; Cai X; Chen M
Cell Commun Signal; 2022 Jul; 20(1):105. PubMed ID: 35842652
[TBL] [Abstract][Full Text] [Related]
8. Targeting DRD2 by the antipsychotic drug, penfluridol, retards growth of renal cell carcinoma via inducing stemness inhibition and autophagy-mediated apoptosis.
Tung MC; Lin YW; Lee WJ; Wen YC; Liu YC; Chen JQ; Hsiao M; Yang YC; Chien MH
Cell Death Dis; 2022 Apr; 13(4):400. PubMed ID: 35461314
[TBL] [Abstract][Full Text] [Related]
9. Molecular Mechanisms of Chemoresistance Induced by Cisplatin in NSCLC Cancer Therapy.
Kryczka J; Kryczka J; Czarnecka-Chrebelska KH; Brzeziańska-Lasota E
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445588
[TBL] [Abstract][Full Text] [Related]
10. SIRT1/PGC-1α/PPAR-γ Correlate With Hypoxia-Induced Chemoresistance in Non-Small Cell Lung Cancer.
Xu R; Luo X; Ye X; Li H; Liu H; Du Q; Zhai Q
Front Oncol; 2021; 11():682762. PubMed ID: 34381712
[TBL] [Abstract][Full Text] [Related]
11. Resveratrol-induced Sirt1 phosphorylation by LKB1 mediates mitochondrial metabolism.
Huang Y; Lu J; Zhan L; Wang M; Shi R; Yuan X; Gao X; Liu X; Zang J; Liu W; Yao X
J Biol Chem; 2021 Aug; 297(2):100929. PubMed ID: 34216621
[TBL] [Abstract][Full Text] [Related]
12. p53 Affects PGC1α Stability Through AKT/GSK-3β to Enhance Cisplatin Sensitivity in Non-Small Cell Lung Cancer.
Deng X; Li Y; Gu S; Chen Y; Yu B; Su J; Sun L; Liu Y
Front Oncol; 2020; 10():1252. PubMed ID: 32974127
[TBL] [Abstract][Full Text] [Related]
13. SREBP1 regulates mitochondrial metabolism in oncogenic KRAS expressing NSCLC.
Ruiz CF; Montal ED; Haley JA; Bott AJ; Haley JD
FASEB J; 2020 Aug; 34(8):10574-10589. PubMed ID: 32568455
[TBL] [Abstract][Full Text] [Related]
14. Metformin selectively inhibits metastatic colorectal cancer with the
Xie J; Xia L; Xiang W; He W; Yin H; Wang F; Gao T; Qi W; Yang Z; Yang X; Zhou T; Gao G
Proc Natl Acad Sci U S A; 2020 Jun; 117(23):13012-13022. PubMed ID: 32444490
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
